Exo Therapeutics Funding: $103M Raised, Series B (2021)
Exo Therapeutics is based in Cambridge, Massachusetts. It has raised $103M in total funding. Latest round: Series B.
Exo Therapeutics funding overview
Exo Therapeutics is based in Cambridge, Massachusetts. Exo Therapeutics has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2021. The round record for Exo Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Newpath Partners, Novartis Venture Fund, CRV, 6 Dimensions Capital. 4 distinct backers are named across the disclosed rounds.
Exo Therapeutics at a glance
Total raised
$103M
Latest round
Series B
Latest round date
October 2021
Headquarters
Cambridge, Massachusetts
Notable investors
Newpath Partners, Novartis Venture Fund, CRV, 6 Dimensions Capital
Frequently asked about Exo Therapeutics funding
How much has Exo Therapeutics raised?
Exo Therapeutics has raised $103M in total disclosed funding across the rounds on record.
Who has invested in Exo Therapeutics?
Newpath Partners, Novartis Venture Fund, CRV, 6 Dimensions Capital are named among the investors backing Exo Therapeutics.
What was the latest Exo Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2021.
Where is Exo Therapeutics based?
Exo Therapeutics is based in Cambridge, Massachusetts.
When did Exo Therapeutics last raise?
The last disclosed Exo Therapeutics round closed in October 2021 at Series B.
Totals shown for Exo Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
